Di Pietro Partners are investigating injury claims associated with DePuy hip replacement devices. Since 2010, there have been several recalls on DePuy hip implants. These recalls were due to issues/injuries reported by patients including, metal poisoning, tumor formation, prolonged pain, and more. As a result, patients suffering from complications may be eligible to file a lawsuit against the manufacturer and receive compensation. It’s important to note, there’s a statute of limitation on these metal hip injury claims; thus, it’s vital to seek legal and medical advice as soon as possible.
DePuy Hip Replacement Recall & Litigation
Our law firm is a team of experienced medical device injury lawyers that work with board certified medical professionals. We pursue these cases anywhere in the United States and are dedicated to getting our clients the compensation they deserve. Therefore, If you or someone you know were affected by a defective DePuy hip replacement, contact us for a free and confidential case evaluation today.
See a list of other defective metal hip replacement devices here
Email us for a free consultation
Background and Devices
DePuy Synthes is a conglomerate of orthopedic and neurosurgery companies that are primarily focused in the manufacturing, marketing, and distribution of medical devices. In 1998, DePuy was acquired by a larger pharmaceutical company, Johnson & Johnson for $3.5 billion. These large medical device companies have been the subject of great controversy regarding their defective metal hip devices including a recent $400 million dollar settlement in 2019. See a list of specific problematic DePuy hip replacements below.
DePuy ASR – The DePuy ASR Acetabular Hip Replacement System originally became available in the U.S in 2005. The FDA provided Johnson & Johnson special clearance to sell these devices prior to performing clinical trials. As a result, DePuy began issuing a recall in 2010.
DePuy Pinnacle – The DePuy’s Pinnacle hip replacement has not been recalled; however, patients commonly report issues in the Metal version of the device. As a result, the device has been the subject of litigation and the Metal version was discontinued.
If you or a loved one experienced injury due to one of these faulty devices, you may be entitled to compensation. Please note, a hip replacement device does not require a recall for litigation. Therefore, if you wish to file a lawsuit, or learn more about the issue, call an experienced attorney today. 1.800.712.8462
Symptoms of DePuy Hip Replacement Failure
Issues associated with hip replacement failure in DePuy devices include:
- Pain – Generally in the hip joint.
- Loosening – This can lead to increasing levels of pain
- Osteolysis – Bone loss
- Metallosis – Metal accumulation in soft tissue around the hip implant
- Pseudotumors – A soft tissue mass that occurs in the area of the implant
- Dislocation – The prosthetic ball may become dislodged from the socket
Patients affected by these hip replacement complications are pursuing lawsuits against the manufacturer for costs associated with revision surgery, as well as pain & suffering experienced from faulty devices. As of 2014, an estimated 93,000 people have received an ASR implant; thus, DePuy will likely continue facing thousands of lawsuits.
Metallosis From DePuy Hip Implants
Metallosis or metal poisoning is a condition which occurs after metallic components from hip replacements rub against one another resulting in the accumulation of metal in the body’s soft tissue. This accumulation of metal debris in the bloodstream can cause extreme health complications, including death. An article published by Consumer Reports provides information on the dangers associated with DePuy metal hip implants; the article cites, “…if your prosthetic hip is metal-on-metal, regardless of what company made the device, you should make sure your doctors know about the trouble with these prosthetics, and you should consider having your blood tested for elevated levels of cobalt and chromium (both of which are toxic metals).” (Consumer Reports, December 5, 2016)